FUNDC1 modulates mitochondrial defects and pancreatic ß-cell dysfunction under lipotoxicity.

Tong, Beier; Zhang, Zhengwei; Li, Xuefeng; Liu, Jie; Wang, Huawei; Song, Linyang; Feng, Jieyuan; Dai, Zhe; Xu, Yancheng

Tong, Beier; Zhang, Zhengwei; Li, Xuefeng; Liu, Jie; Wang, Huawei; Song, Linyang; Feng, Jieyuan; Dai, Zhe; Xu, Yancheng.

Affiliation

Tong B; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Zhang Z; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Li X; Department of Endocrinology, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, China.
Liu J; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Wang H; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Song L; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Feng J; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Dai Z; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: daizhe@znhospital.cn.
Xu Y; Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: xjl100901@whu.edu.cn.

Biochem Biophys Res Commun ; 672: 54-64, 2023 09 10.

Article de En | MEDLINE | ID: mdl-37336125

Sujet(s)
Mots clés

FUNDC1; Insulin resistance; Mitochondrial dysfunction; Palmitate; Pancreatic ß-cell

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance Limites: Animals Langue: En Journal: Biochem Biophys Res Commun Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google